Brain metastases (BMs) are the most common intracranial tumor type and a significant
health concern, affecting approximately 10% to 30% of all oncological patients. Although …

Sex differences are increasingly being explored and reported in oncology, and glioma is no
exception. As potentially meaningful sex differences are uncovered, existing gender-derived …

Human cancers are biologically and morphologically heterogeneous. A variety of clonal
populations emerge within these neoplasms and their interaction leads to complex …

Current clinical decision-making in oncology relies on averages of large patient populations
to both assess tumour status and treatment outcomes. However, cancers exhibit an inherent …

Increased intracranial pressure is the source of most critical symptoms in patients with
glioma, and often the main cause of death. Clinical interventions could benefit from non …

Objective Glioblastoma (GBM) is the most common primary malignant neoplasm of the
central nervous system (CNS). Despite the progress in therapeutic strategies such as …

Imaging is central to the clinical surveillance of brain tumors yet it provides limited insight
into a tumor's underlying biology. Machine learning and other mathematical modeling …

Equation learning methods present a promising tool to aid scientists in the modeling process
for biological data. Previous equation learning studies have demonstrated that these …

The reaction-diffusion equation is widely used in mathematical models of cancer. The
calibration of model parameters based on limited clinical data is critical to using reaction …

Brain metastases (BMs) are cancer cells that spread to the brain from primary tumors in
other organs. Up to 35% of adult cancer patients develop BMs. The treatment of BM patients …